Descripción de la calidad de vida y evaluación del nivel de conocimiento de un individuo con síndrome de Marfan sobre su enfermedad y el tipo de mutación que se presenta a nivel molecular

datacite.rightshttp://purl.org/coar/access_right/c_16ecspa
dc.contributor.advisorTrindade, Cristiano
dc.contributor.authorGalindo Ballestas, Luisa Fernanda
dc.contributor.authorManjarrez Araujo, Oriana Masiel
dc.contributor.authorPáez Noriega, Rosalía
dc.date.accessioned2021-08-19T16:31:06Z
dc.date.available2021-08-19T16:31:06Z
dc.date.issued2019
dc.description.abstractEl síndrome de Marfan (SMF) es una enfermedad del sistema conectivo de tipo autosómica dominante de afección multiorgánica. Su buen pronóstico dependerá de un eficiente diagnóstico, tratamiento y al acoplamiento del paciente. El objetivo del proyecto se basa en la descripción de la calidad de vida y evaluación del nivel de conocimiento de un individuo con MFS sobre su enfermedad, sus manifestaciones, tratamientos y recomendaciones. Para ello se realizó un cuestionario, con puntos detallados, tales como: tiempo de diagnóstico, seguimiento por especialidades médicas, problemas de salud implicados por el síndrome, entre otras. Los resultados obtenidos en la encuesta muestran que el paciente, respecto a puntos generales de la enfermedad indicó como verdaderas 41% de las preguntas, un 27% de falsos, y no sabe o indica no tener conocimiento en un 32%, los cual indica un poco de vacío en cuanto a conocimiento. Conclusión: el conocimiento de SMF permite llevar una buena calidad de vida ya que hay una mejor adaptación al tratamiento recibido; lo cual mejora la resolución del cuadro a presentar.spa
dc.description.abstractMarfan syndrome (MFS) is an autosomal dominant connective system disease of a multiorgan condition. the good prognosis will depend on an efficient diagnosis, treatment and coupling of the patient. The objective of the project is based on the description of the quality of life and evaluation of the level of knowledge of an individual with SFM about his disease, its manifestations, treatments and recommendations. To do this, a questionnaire was carried out, with detailed points, such as: diagnostic time, follow-up by medical specialties, health problems implicated by the syndrome, among others. The results obtained in the survey show that the patient, regarding general points of the disease indicated as true 41% of the questions, 27% false, and does not know or indicates not having knowledge in 32%, which indicates a bit of a vacuum in terms of knowledge. Conclusion: Knowledge of MFS allows a good quality of life, since there is a better adaptation to the treatment received, which improves the resolution of the table to be presented.eng
dc.format.mimetypepdfspa
dc.identifier.urihttps://hdl.handle.net/20.500.12442/8133
dc.language.isoengspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectSíndrome de Marfanspa
dc.subjectDilatación aorticaspa
dc.subjectTratamiento y seguimientospa
dc.subjectMarfan syndromeeng
dc.subjectAortic dilationeng
dc.subjectTreatment and follow-upeng
dc.titleDescripción de la calidad de vida y evaluación del nivel de conocimiento de un individuo con síndrome de Marfan sobre su enfermedad y el tipo de mutación que se presenta a nivel molecularspa
dc.type.driverinfo:eu-repo/semantics/bachelorThesisspa
dc.type.spaTrabajo de grado - pregradospa
dcterms.referencesAchelrod, Dmitrij; Blankart, Carl Rudolf; Linder, Roland; Von Kodolitsch, YsKert; Stargardt, Tom (2014) "The economic impact of Marfan syndrome: a nonexperimental, retrospective, population-based matched cohort study" Orphanet Journal of Rare Diseases. 9(90), 1-12.Arn et al., 1989eng
dcterms.referencesArn, Pamela H.; Scherer, L. R.; Haller Jr, Alex; Pyeritz, Reed E. (1989) "Outcome of pectus excavatum in patients with Marfan syndrome and in the general population" The Journal of Pediatrics. 115(6), 954–958.eng
dcterms.referencesBaumgartner, H.; Bonhoeffer, P.; De Groot, N. ; De Haan, F.; Deanfield, J.; Galie, N.; ... Westby, J. (2010) "ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)" European Heart Journal. 31(23), 29152957.eng
dcterms.referencesBennett, P. (2002) Introdução Clínica à Psicologia da Saúde. Lisboa: Manuais Universitários. Climepsi Editores.pt
dcterms.referencesBennett, Paul; Murphy, Simone (1999) Psicologia e promoção da saúde. Lisboa: Manuais Universitários. Climepsi Editores.pt
dcterms.referencesCosta, Miguel; López, Ernesto (1998) Educación para la salud: Una estrategia para cambiar los estilos de vida. Madrid: Ediciones Pirâmidespa
dcterms.referencesDavies, Ryan R.; Goldstein, Lee J.; Coady, Michael A.; Elefteriades, John A. (2002) "Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size" The Annals of Thoracic Surgery. 73(1), 17- 27.eng
dcterms.referencesDe Bie, Sylvia; De Paepe, Anne; Delvaux, Isabelle; Davies, Sally; Hennekam, Raoul (2004) "Marfan syndrome in Europe: A questionnaire study on patients perceptions" Community Genetics. 7(4), 216–225eng
dcterms.referencesDe Paepe, Anne; Devereux, Richard B.; Dietz, Herry C.; Hennekam, Raoul; Pyeritz, Reed E. (1996) "Revised diagnostic criteria for the Marfan syndrome" American Journal of Medical Genetics. 62(4), 417–426eng
dcterms.referencesDietz, Harry C.; Cutting, Carry R.; Pyeritz, Reed E.; Maslen, Cheryl L.; Sakai, Lynn; Corson, Glen M.; Puffenberger, Erik G.; Hamosh, Ada; Nanthakumar, Elizabeth J. ; Curristin, Sheila M. ; Stetten, Gail ; Meyers, Deborah A. ; Francomano, Clair A. (1991) “Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene” Nature. 352, 337–339eng
dcterms.references.Engelfriet, Peter; Mulder, Barbara (2007) "Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome?" International Journal of Cardiology. 114(3), 300–302eng
dcterms.referencesGiarelli, Ellen; Bernhardt, Barbara A.; Mack, Rita; Pyeritz, Reed E. (2008) "Adolescents’ transition to self-management of a chronic genetic disorder" Qualitative Health Research. 18(4), 441-457.eng
dcterms.referencesGiarelli, Ellen; Bernhardt, Barbara A.; Pyeritz, Reed E. (2010) "SelfSurveillance by Adolescents and Young Adults Transitioning to SelfManagement of a Chronic Genetic Disorder" Health Education & Behavior. 37(1), 133-150eng
dcterms.referencesGroenink, M.; Lohuis, T.; Tijssen, J.; NaeV, M.; Hennekam, R.; van der Wall, E.; Mulder, B. (1999) “Survival and complication free survival in Marfan’s syndrome: implications of current guidelines” Heart. 82, 499-504.eng
dcterms.referencesGroenink, Maarten; de Ross, Albert; Mulder, Barbara J.; Spaan, Jos A.; van der Wall, Ernst (1998) “Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome” The American Journal of Cardiology. 82(2), 203-208eng
dcterms.referencesHofman, Karen J.; Bernhardt, Barbara A.; Pyeritz, Reed E.; Opitz, John M.; Reynolds, James F. (1988) “Marfan syndrome: Neuropsychological aspects” American Journal of Medical Genetics. 31(2), 331-338eng
dcterms.referencesJorde, Lynn B., Carey, John C.; Bamshad, Michael J.; White, Raymond (2010) Genética Médica. Rio de Janeiro: Elsevierspa
dcterms.referencesJudge, Daniel P.; Dietz, Harry C. (2005) “Marfan’s syndrome” The Lancet. 366(9501), 1965-1976eng
dcterms.referencesKole, Anna; Faurisson, Françoise (2009) The Voice of 12,000 Patients. Boulogne-Billancourt: EURORDISpt
dcterms.referencesLoewenstein, Anat ; Barequet, Irina ; De Juan, Eugene Jr ; Maumenee ; Irene (2000) “Retinal detachment in Marfan Syndrome” Retina. 20(4), 58–63.eng
dcterms.referencesLoeys, B.; De Backer, J.; Van Acker, P.; Wettinck, K.; Pals, G.; Nuytinck, L.; Coucke, P.; De Paepe, A. (2004) “Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome” Human Mutation. 24(2), 140-146.eng
dcterms.referencesLoeys, Bart ; Dietz, Harry ; Braverman, Alan ; Callewaert, Bert ; De Backer, Julie ; Devereux, Richard ; Hilhorst-Hofstee, Yvonne ; Jondeau, Guillaume ; Faivre, Laurence ; Milewicz, Dianna ; Pyeritz, Reed ; Sponseller, Paul ; Wordsworth, Paul ; De Paepe, Anne (2010) “The revised Ghent Nosology for the Marfan syndrome” Journal of Medical Genetics. 47(7), 476– 485.eng
dcterms.referencesLoeys, Bart; Nuytinck, Lieve; Delvaux, Isabelle; De Die, Sylvia; De Paepe, Anne (2001) “Genotype and Phenotype Analysis of 171 Patients Referred for Molecular Study of the Fibrillin-1 Gene FBN1 Because of Suspected Marfan Syndrome” JAMA Internal Medicine. 161(20), 2447–2454eng
dcterms.referencesMarfan, Antonin B. J. (1896) Un cas de déformation congénitale des quarte membres, plus prononcée aux extrémités, caractérisée par l’allongement des os avec un certain degré d’amincissement. Paris: Impr. Maretheuxeng
dcterms.referencesMoons, Ju R.; Cho, Yong A.; Huh, June; Kang, I-Seok; Kim, Duk-Kyung (2016) "Structural equation modeling of the quality of life for patients with marfan syndrome" Health and Quality of Life Outcomes. 14(83), 1-9.eng
dcterms.referencesMoons, P.; De Volder, E.; Budts, W.; De Geest, S.; Elen, J.; Waeytens, K.; Gewillig, M. (2001) "What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education" Heart. 86(1), 74-80eng
dcterms.referencesMurdoch, J. Lamont; Walker, Bryan A.; Halpern, Barry L.; Kuzma, Jan W.; Mckusick, Victor A. (1972) “Life Expectancy and Causes of Death in the Marfan Syndrome” The New England Journal of Medicine. 286(15), 804–808.eng
dcterms.referencesOgden, Jane (2004) Health Psychology: A Textbook. Berkshire: Open University Presseng
dcterms.referencesOrphanet (2016) Prevalence and Incidence of Rare Diseases: Bibliographic Data. Paris: Orphanet Report Serieseng
dcterms.referencesPeters, K. F.; Apse, K. A.; Blackford, A.; McHugh, B.; Michalic, D.; Biesecker, B. B. (2005) "Living with Marfan syndrome: coping with stigma" Clinical Genetics. 68(1), 6-14.eng
dcterms.referencesPeters, K. F.; Kong, F.; Horne, R.; Francomano, C. A.; Bieseceker, B. B. (2001a) “Living with Marfan syndrome I. Perceptions of the condition” Clinical Genetics. 60, 273-282eng
dcterms.referencesPeters, K. F.; Horne, R.; Kong, F.; Francomano, C. A.; Bieseceker, B. B. (2001b) “Living with Marfan syndrome II. Medication adherence and physical activity modification” Clinical Genetics. 60(4), 283-292.eng
dcterms.references.Peters, K. F.; Kong, F.; Hanslo, M.; Bieseceker, B. B. (2002) “Living with Marfan syndrome III. Quality of life and reproductive planning” Clinical Genetics. 62, 110-120.eng
dcterms.referencesPyeritz, R. E. (2007) "Marfan syndrome and related disorders" in Rimoin, D.; Connor, J.; Pyeritz, Reed; Korf, B. (eds.) Emery and Rimoin’s principles and practice of medical genetics. Philadelphia: Churchill Livingstone Elsevier, 3579-3624eng
dcterms.referencesRand-Hendriksen, Svend; Johansen, Heidi; Semb, Svein O.; Geiran, Odd; Stanghelle, Johan K.; Finset, Arnstein (2010) "Health-related quality of life in Marfan syndrome: A cross-sectional study of Short Form 36 in 84 adults with a verified diagnosis" Genetics in Medicine. 12(8), 517–524.eng
dcterms.referencesRobinson, Peter N.; Godfrey, Maurice (2000) “The molecular genetics of Marfan syndrome and related microfibrillopathies” Journal of Medical Genetics. 37(1), 9-25eng
dcterms.referencesSalim, M. A.; Alpert, B. S. (2001) "Sports and Marfan Syndrome - awareness and early diagnosis can prevent sudden death" The Physician and Sportsmedicine. 29(5), 80-93eng
dcterms.referencesSchneider, Marcie B.; Davis, Jessica G.; Boxer, Robert A.; Fisher, Martin; Friedman, Stanford B. (1990) "Marfan Syndrome in Adolescents and Young Adults: Psychosocial Functioning and Knowledge". Developmental and Behavioral Pediatrics. 11(3), 122-127.eng
dcterms.referencesShores, Jennifer; Berger, Kenneth R.; Murphy, Edmond; Pyeritz, Reed E. (1994) "Progression of Aortic Dilatation and the Benefit of Long-Term Betaadrenergic blockade in Marfan’s syndrome" The New England Journal of Medicine. 330, 1335– 1341.eng
dcterms.referencesSilverman, David.; Burton, Kevin; Gray, Jonathon; Bosner, Matthew; Kouchoukos, Nicholas; Roman, Mary; Boxer, Maureen; Devereux, Richard; Tsipouras, Petros (1995) "Life expectancy in the Marfan syndrome" The American Journal of Cardioogyl. 75(2), 157-160eng
dcterms.referencesSvensson, Lars; Kouchoukos, Nicholas; Miller, D. Craig; Bavaria, Joseph; Coselli, Joseph; Curi, Michael; Eggebrecht, Holger; Elefteriades, John; Erbel, Raimund; Gleason, Thomas; Lytle, Bruce; Mitchell, R. Scott; Nienaber, Christoph; Roselli, Eric; Safi, Hazim; Shemin, Richard; Sicard, Gregorio; Sundt, Thoralf; Szeto, Wilson; Wheatley, Grayson (2008) "Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-grafts" The Annals of Thoracic Surgery. 85(1), S1–S41.eng
dcterms.referencesVan Tongerloo, A.; DePaepe, A. (1998) "Psychosocial adaptations in adolescents with Marfan syndrome: An exploratory study" Journal of Medical Genetics. 35, 405-409eng
dcterms.referencesVon Kodolitsch, Yskert; De Backer, Julie; Schuler, Helke; Bannas, Peter; Behzadi, Cyrus; Bernhardt, Alexander; Hillebrand, Mathyas; Fuisting, Bettinea; Sheikhzadeh, Sara; Rybczynski, Meike; Kolbel, Tilo; Puschel, Klaus; Blankenberg, Stefan; Robinson, Peter (2015) "Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome" The Application of Clinical Genetics. 8, 137–155eng
dcterms.referencesCook JR, Ramirez F. Clinical, diagnostic, and therapeutic aspects of the Marfan syndrome. Adv Exp Med Biol. 2014. 802 (): 77-94. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24443022.eng
dcterms.referencesSánchez R. Enfermedad de Marfan: revisión clínico-terapéutica y guías de seguimiento. Seminarios de la Fundación Española de Reumatología. 2011; volumen 12 (número 4): 1112-1222. Disponible en: https://www.elsevier.es/es-revista-seminarios-fundacion-espanolareumatologia-274-articulo-enfermedad-marfan-revision-clinicoterapeuticaguias-S1577356611000832.spa
dcterms.referencesGuglielmina Pepe, Betti Giusti, Elena Sticchi, Rosanna Abbate, Gian Franco Gensini y Stefano Nistri. The Application of Clinical Genetics; volumen 9 (): 55–65. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869846/eng
dcterms.referencesPr Guillaume JONDEAU. Síndrome de Marfan. Marzo 2010. Disponible en: https://www.orpha.net/consor/cgibin/Disease_Search.php?lng=ES&data_id=109&Disease_Disease_Search_ diseaseGroup=marfan&Disease_Disease_Search_diseaseType=Pat&Disea se(s)/group%20of%20diseases=Marfan-syndrome&title=Marfansyndrome&search=Disease_Search_Simpleeng
dcterms.referencesMinsalud. Colombia. Enfermedades huérfanas. Disponible en: https://www.minsalud.gov.co/salud/publica/PENT/Paginas/enfermedadeshuerfanas.aspxspa
dcterms.referencesUniversidad del Rosario. 2014. Disponible en: https://es.scribd.com/document/407265284/328902563-Crea-Total-pdfspa
dcterms.referencesSalik I, Rawla P. Marfan Syndrome. [Updated 2019 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537339/.eng
dcterms.referencesBecerra-Muñoz, V. M., Gómez-Doblas, J. J., Porras-Martín, C., SuchMartínez, M., Crespo-Leiro, M. G., Barriales-Villa, R.,… Cabrera-Bueno, F. (2018). The importance of genotype-phenotype correlation in the clinical management of Marfan syndrome. Orphanet Journal of Rare Diseases, 13(1).eng
dcterms.referencesCañadas, V., Vilacosta, I., Bruna, I., & Fuster, V. (2018). Marfan syndrome. Part 1: pathophysiology and diagnosis. Nature Reviews Cardiology, 7(5), 256–265.eng
dcterms.referencesJuez, D. (2019). Síndrome de Marfan. [online] Thelancet.com. Available at: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(05)63106- 6.pdf [Accessed 5 Nov. 2019].eng
dcterms.referencesReyes-Hernández, O., Palacios-Reyes, C., Chávez-Ocaña, S., CortésMalagón, E., Alonso-Themann, P., Ramos-Cano, V., Ramírez-Bello, J. and Sierra-Martínez, M. (2019). Skeletal manifestations of Marfan syndrome associated to heterozygous R2726W FBN1 variant: sibling case report and literature review.eng
dcterms.referencesBarriales-Villa, R., García-Giustiniani, D. and Monserrat, L. (2019). Genética del síndrome de Marfan. [online] Available at: https://www.elsevier.es/esrevista-cardiocore-298-articulo-genetica-del-sindrome-marfanS1889898X11000727 [Accessed 5 Nov. 2019].spa
dcterms.referencesRobbins. Elastina, fibrilina y fibras elásticas. En: Patología Estructural y Funcional. Cotran, Kumar y Collins. 6ª Ed. Madrid, McGraw-Hill Interamericana, 2016. Pág. 106.spa
dcterms.referencesEl síndrome de Marfan – Enciclopedia Orphanet de la Discapacidad www.orpha.net/data/patho/Han/Int/es/Marfan_Es_es_HAN_ORPHA109.pdf | agosto de 2016 Dra. Gisela Teixidó Turà, cardióloga, Unidad del Síndrome de Marfan, Hospital Universitari General Vall d'Hebron, Barcelona (España), agosto de 2016.spa
dcterms.referencesEdison Ricardo Espinoza Saquicela a * , Stefania del Cisne Serrano Olmedo b julio / dic. 2017 ENFERMEDAD AÓRTICA ASCENDENTE EN UN PACIENTE CON SÍNDROME DE MARFAN, scielo vol.3 no.2spa
dcterms.referencesDiagnóstico diferencial del síndrome de Marfan en un atleta de voleibol adolescente En t. J. Cardiovasc. Sci. vol.30 no.2 Rio de Janeiro Mar./Abr. 2017 Revista Internacional de Ciencias Cardiovasculares.spa
dcterms.referencesJuan G. Barrera, MD.(1); Camilo Espinel, MD.(1); Jaime Amarillo, MD.(1); Víctor R. Castillo, MD.(1); Antonio Figueredo, MD.(1); Javier Gentile, MD.(1); Walter Mosquera, MD.(1); Sebastián Balestrini, MD.(1); Leonardo Salazar, MD.(1); Adriana S. Murcia, MD.(1) , Endovascular treatment of an aneurysm of the descending aorta in an adolescent with Marfan síndrome , Rev. Colomb. Cardiol. vol.19 no.1 Bogota Jan./Feb. 2012eng
dcterms.referencesDaisy Venancio, Síndrome de marfan, Born and Grow vol.25 supl.1 Porto dez. 2016eng
dcterms.referencesSadık Görkem Çevik 1 Muhammer Özgür Çevik 2 Ahmet Tuncer Özmen 3 Implante de lente intraocular de fixação iriana em crianças com ectopia lentis Arq. Bras. Oftalmol vol.80 no.2 São Paulo Mar./Abr. 2017pt
dcterms.referencesS Williams-Phillips 1 H Vaughn 1 Síndrome de Marfan: ¿presentación clínica con glaucoma congénito? West Indian med. j. vol.67 no.1 Mona ene./mar. Epub 2018 18 de julio de 2019spa
dcterms.referencesWillian Caetano RODRIGUES 1 Mário Francisco Real GABRIELLI1 Marina Reis OLIVEIRA 1 Ana Claudia Gabrielli PIVETA 2 Marisa Aparecida Cabrini GABRIELLI 1 Tratamiento quirúrgico de ortodoncia de un paciente con síndrome de Marfan y síndrome de apnea obstructiva del sueño: reporte de caso con 9 años de seguimiento RGO, Rev. Gaúch. Odontol. vol.67 Campinas 2019 Epub Oct 28, 2019spa
dcterms.references10. Kelly Jr RE. Pectus excavatum:historical background, clinical picture, preoperative evaluation and criteria for operation. Semin Pediatr Surg. 2008;17:181-93.eng
dcterms.referencesLesbo M, Tang M, Nielsen HH, Frøkiær J, Lundorf E, Pilegaard HK, et al. Compromised cardiac function in exercising teenagers with pectus excavatum. Interact Cardiovasc Thorac Surg. 2011;13:377-80.eng
dcterms.referencesMaría Elena Soto1, Roberto Cano2, C. Sergio Criales3, Leonel Avendaño4, Nilda Espínola4, Carlos García5 Pectus excavatum y carinatum en el síndrome de Marfan y síndromes similares: prevalencia e impacto clínico pulmonar y cardiovascular Gaceta Med Mex. 2018;154(Suppl 2): S67-S78.spa
dcterms.referencesalvarez palacios franklin santiago (2016) revisión bibliográfica y presentación de un caso:síndrome de marfán[online]. Revista de la facultad de ciencias medicas,universidad de cuenca.spa
dcterms.referencesRand-Hendriksen, Svend; Johansen, Heidi; Semb, Svein O.; Geiran, Odd; Stanghelle, Johan K.; Finset, Arnstein (2010) "Health-related quality of life in Marfan syndrome: A cross-sectional study of Short Form 36 in 84 adults with a verified diagnosis" Genetics in Medicine. 12(8), 517–524.eng
dcterms.referencesMoons, P.; De Volder, E.; Budts, W.; De Geest, S.; Elen, J.; Waeytens, K.; Gewillig, M. (2001) "What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education" Heart. 86(1), 74-80.eng
dcterms.referencesMoons, Ju R.; Cho, Yong A.; Huh, June; Kang, I-Seok; Kim, Duk-Kyung (2016) "Structural equation modeling of the quality of life for patients with marfan syndrome" Health and Quality of Life Outcomes. 14(83), 1-9.eng
oaire.versioninfo:eu-repo/semantics/acceptedVersionspa
sb.programaMedicinaspa
sb.sedeSede Barranquillaspa

Archivos

Colecciones